Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Neuropeptide S ELISA Kit (AC3939)
Cat.#: ASET-2528
Specifications
Description Human Neuropeptide S ELISA Kit allows for the in vitro quantitative determination of human Neuropeptide S concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1698 Human Copeptin ELISA Kit (AC3109) Quantitative inquiry ASET-1556 Rat CYP1B1 ELISA Kit (AC2967) Quantitative inquiry ASET-1076 Sheep eNOS ELISA Kit (AC2487) Quantitative inquiry ASET-2476 Human Syndecan 4 ELISA Kit (AC3887) Quantitative inquiry ASET-1205 Rat PON2 ELISA Kit (AC2616) Quantitative inquiry ASET-1608 Mouse LRP5 ELISA Kit (AC3019) Quantitative inquiry ASET-1257 Mouse Calbindin ELISA Kit (AC2668) Quantitative inquiry ASET-1754 Human TRPV2 ELISA Kit (AC3165) Quantitative inquiry ASET-2339 Human Cathepsin B ELISA Kit (AC3750) Quantitative inquiry ASET-1964 Human Prol1 ELISA Kit (AC3375) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket